Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens, and assay kits, has announced its Hantavirus Research Reagents and Products to support hantavirus research and diagnostic assay development. This comprehensive catalog aims to help academic researchers, biopharmaceutical companies, and industrial organizations accelerate the development of diagnostic assays and therapeutic interventions targeting dangerous rodent-borne orthohantaviruses.
Hantaviruses are emerging zoonotic pathogens classified as Category A pathogens by the US Centers for Disease Control and Prevention (CDC). They pose a serious threat to human health, causing haemorrhagic fever with renal syndrome (HFRS) or hantavirus cardiopulmonary syndrome (HCPS), both highly fatal. The viruses are transmitted to humans via aerosols containing excreta from infected rodent hosts.
Hantaviruses possess a tripartite negative-strand RNA genome. The three genomic RNA segments (S, M, and L) encode the nucleocapsid protein (N), a precursor glycoprotein (which forms two envelope glycoproteins, Gn and Gc upon processing), and the viral RNA-dependent RNA polymerase (RdRp). The N protein is the virus's primary structural component, protecting and encapsulating the three genomic RNA strands to form viral ribonucleocapsids. Recent studies suggest that the N protein acts with RdRp to play a crucial role in viral genome transcription and replication, and it preferentially promotes viral mRNA translation within the cell.
Currently, no antiviral therapies or vaccines are available for hantavirus-associated diseases. A deeper understanding of the molecular mechanisms underlying the hantavirus life cycle could identify targets for antiviral therapy and help design potential drugs to treat HFRS and HCPS. Given the high case-fatality rate of hantavirus diseases, developing an effective vaccine is imperative.
Early clinical manifestations of hantavirus infection often resemble common seasonal respiratory or influenza-like illnesses, creating an urgent need for highly sensitive, reliable, and standardized laboratory diagnostic tools for early differential diagnosis and accurate target validation. To address these challenges, Creative Diagnostics offers a range of hantavirus research reagents and products covering multiple strains, including Hantavirus, Puumala virus (PUUV), Seoul virus (SEOV), and Sin Nombre virus (SNV).
Creative Diagnostics' new product line includes recombinant hantavirus antigens for assay development; high-affinity monoclonal and polyclonal antibodies validated for capture and detection across multiple platforms, including Western blot, flow cytometry, immunohistochemistry, and surface plasmon resonance; and supporting reagents for ELISA and rapid immunoassay research. For detailed product specifications, volume pricing, or to browse the complete list of available viral solutions, visit the official product portal at https://www.creative-diagnostics.com/hantavirus.htm.
